,,iv  #aad? ,,congress  #b;d ,session   
,h4 ,,res4 #ehf  ,,9 ,,! ,,h\se ,,(     
,,repres5tatives  ,janu>y #ac1 #bjaf    
,mr4 ,knight 7= himself1 ,ms4 ,spei]1   
,mr4 ,mc,caul1 ,mr4 ,van ,holl51 ,mr4   
,*abot1 ,ms4 ,e%oo1 ,mr4 ,crd5as1 & ,mr4
 ,cony]s7 submitt$ ! foll[+ resolution2 
:i* 0 ref]r$ to ! ,committee on ,en]gy &
 ,comm]ce  ,,resolution  ,express+      
support = designation ( ! f\r? week 9   
,may z ,,dipg ,aw>5ess ,week to raise   
aw>5ess & enc\rage ! rese>* into cures =
 diffuse intr9sic pont9e glioma 7,,dipg7
 & p$iatric canc]s 9 g5]al4  ,:]eas     
diffuse intr9sic pont9e glioma 7,,dipg7 
affects #bjj to #djj *ildr5 9 ! ,unit$  
,/ates ea* ye>2 ,:]eas bra9 tumors are !
 lead+ cause ( canc]-relat$ dea? 9      
*ildr52 ,:]eas ,,dipg is ! second mo/   
common malignant bra9 tumor ( *ildhood2 
,:]eas ,,dipg is ! lead+ cause (        
*ildhood dea? due to bra9 tumors2 ,:]eas
 ! m$ian survival is only #i mon?s2     
,:]eas #e-ye> survival is less ?an #a   
p]c5t2 ,:]eas giv5 ! age at diagnosis & 

! av]age life expectancy1 ! numb] ( life
 ye>s lo/ annually because ( ,,dipg is  
approximately #be1jjj ye>s ( p]son life 
lo/ 7calculat$ z ! numb] ( *ildr5       
diagnos$ by av]age ( male & female life 
expectancy f t m$ian age1 #cjj  #hj     
#be1jjj ye>s ( p]son life lo/ annually72
 & ,:]eas prognosis has n improv$ =     
*ildr5 ) ,,dipg 9 ov] #ce ye>s3 ,n[1    
!re=e1 be x ,t ! ,h\se (                
,repres5tatives--  7#a7 supports !      
designation ( ,,dipg ,aw>5ess ,week2    
7#b7 enc\rages all p ( ! ,unit$ ,/ates  
to become m in=m$ ab\t diffuse intr9sic 
pont9e glioma 7,,dipg7 & p$iatric bra9  
canc]2  7#c7 supports exp&$ rese>* to   
bett] und]/& ,,dipg1 develop effective  
treatm5ts1 & provide compreh5sive c>e = 
*ildr5 ) ,,dipg & _! families2 &  7#d7  
enc\rages ! ,,nci & o!r rese>* fund]s to
 elevate _! consid]ation ( mortality    
rate ( a type ( canc] z well z ! life   
ye>s lo/ z factors consid]$ dur+ ! grant
 application process4